Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Notification

Havrix monodose supply constraint

Due to manufacturing issues, UK availability of monovalent hepatitis A vaccine (Havrix Monodose) from GlaxoSmithKline (GSK) will be reduced during 2015. GSK will prioritise the remaining stock for GPs, hospitals, travel clinics and occupational health practitioners. Alternative hepatitis A vaccines are available from other manufacturers and combination hepatitis A vaccines remain available from GSK. Normal supply is expected to resume by early 2016. Further information on 0800 221441.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067168

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.